Demis Hassabis, a key figure in AI, is stepping into a new role at Google Deep Mind and Alphabet as chief scientist. This leadership change, however, has concerned investors, impacting the company's share price.

Hassabis, who founded Deep Mind before Google acquired it, has consistently emphasized AI's potential as a scientific tool, citing breakthroughs like Alpha Go and Alpha Fold. He believes Artificial General Intelligence (AGI) is within reach and intends to focus on strategic AGI matters, advising his successor Koray Kavukcuoglu, and dedicating time to his AI drug discovery company, Isomorphic Labs.

This shift highlights a tension within Google's AI strategy: Hassabis' scientific aspirations versus the company's need for rapid commercialization and monetization. Facing intense competition from rivals like OpenAI and Anthropic, and with Alphabet planning significant capital expenditure, the move suggests a recalibration towards faster product deployment, even as Hassabis stresses responsible AI development amidst a global AGI race.